Left Atrial Spontaneous Echo Contrast: Pathogenesis, Detection, and Modelling

The left atrium (LA) is particularly susceptible to blood stasis in conditions like atrial fibrillation (AF), which can lead to thrombus formation, especially in the left atrial appendage. Spontaneous echo contrast (SEC) in the LA, detectable via transesophageal echocardiography (TEE), occurs when blood flow slows, and has been strongly associated with thrombus formation and increased stroke risk, making it an important prognostic indicator. The underlying mechanism of LA SEC is thought to involve echogenic red blood cell aggregates formed due to low shear rates, but the roles of platelets and the coagulation cascade remain unclear. Given that LA SEC is considered a precursor to thrombus formation, enhancing our understanding of its pathophysiology may offer insights into thrombogenesis inside the LA, which to date remains poorly understood. The development of noninvasive diagnostic tools for LA SEC is critical, as TEE, whereas the gold standard is invasive and not universally accessible. Promising alternatives, such as harmonic transthoracic echocardiography and biphasic computed tomography imaging, have shown potential in diagnosing LA SEC and assessing stroke risk in AF patients. Additionally, emerging technologies like computational modelling are offering new avenues for understanding the mechanisms of LA SEC, with blood flow simulations providing valuable insights into its formation. These advancements could improve diagnostic capabilities and stroke risk stratification in AF patients, highlighting the need for further research to fully elucidate the clinical implications of LA SEC.